EUROPEAN JOURNAL OF CANCER, cilt.67, ss.183-190, 2016 (SCI-Expanded)
Aim: To assess trends in survival and geographic disparities among children (0-14 years) with chronic myeloid leukaemia (CML) before and after the introduction of molecular therapy, namely tyrosine kinase inhibitors (TKIs) in Southern-Eastern European (SEE) countries and the USA.